Reglan Side Effects Are Serious And Lifelong

Reglan (metoclopramide) is often prescribed to treat individuals with gastrointestinal problems. In February of 2009, the United States Food and Drug Administration (FDA) issued an advisory requiring the manufacturers of Reglan to update their label. The advisory called for a black box warning, the strongest warning issued by the FDA, regarding the risk of individuals developing tardive dyskinesia.

Tardive dyskinesia is most often characterized by repetitive, involuntary movements. Tardive dyskinesia is a devastating and sometimes lifelong syndrome. At this time, there is no known treatment for tardive dyskinesia. It is important to know that the FDA has approved Reglan only for short-term use (4 to 12 weeks) and only when conservative treatment fails.

Let Us Work To Get The Compensation You Need. You Just Have To Call.

If you or a loved one has taken Reglan and been diagnosed with tardive dyskinesia, you may be entitled to compensation for your injuries.

Our attorneys are here to help you obtain compensation for your injuries due to Reglan use. Please contact us today for a free evaluation by calling James F. Humphreys & Associates, L.C., at 304-881-0652 or by completing our online form.